
The approval makes omalizumab the first and only FDA-approved medicine to reduce allergic reactions in patients with one or more food allergies.

The approval makes omalizumab the first and only FDA-approved medicine to reduce allergic reactions in patients with one or more food allergies.

The Orphan Drug Designation follows the receipt of Rare Pediatric Disease Designation from the FDA in January 2024.

Lawrence Eichenfield, MD, highlights the sNDA submission of tapinarof cream, 1% for the topical treatment of atopic dermatitis in children aged 2 years and older.

Promoting mental health and implementing stress-reducing scenarios for adolescents could lessen motivating factors for substance use.

Results demonstrated that foster care involvement does vary based on age and sex, with Black youths and females disproportionately effected.

The sNDA submission follows additional positive topline data that was presented in Janurary 2024, highlighting an open-label, long-term extension study evaluating tapinarof cream, 1%.

Compared to children with no maternal tobacco usage during pregnancy, those exposed had associations to childhood neurocognition deficits.


The review and meta-analysis reaffirmed previous data regarding maternal asthma and neonatal outcomes while also uncovering several novel findings.

Discover how recent research unveils the potential of psychological interventions in alleviating asthma attacks and mitigating associated psychological stressors, shedding light on promising avenues for asthma management.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The twice-daily oral corticosteroid is indicated for 12 weeks of treatment.

Contemporary Pediatrics editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights our special nutrition issue, published for January/February, 2024.

Discover effective counseling techniques and overcome barriers to empower adolescents in making informed decisions about contraception, fostering trust, confidentiality, and autonomy in reproductive health care.

The child was otherwise healthy with no prior severe medical issues, and he did not present with COVID-19 symptoms. Can you diagnose this child based on the case below?

Joshua Feder, MD, explains how developmental care models for autism care can benefit children with autism, providers, parents, and other family members.

Samantha Olson, MPH, explains the important role of a strong recommendation for maternal influenza vaccination.

Deborah Persaud, MD, details results from her study that aimed to reduce HIV reservoirs in neonates with very early antiretroviral therapy.

Read the case and take your best guess at diagnosing this 4-year-old patient.

Weight can mean a lot of things. Context is important, and different measurements are used for specific goals.

Samantha Olson, MPH, breaks down a study highlighting the effectiveness of maternal influenza vaccination and its respective association with influenza-related hospitalizations in infants.

Investigators recently noted that despite a decrease in adolescent hospital visits during the height of the pandemic, there was an increase in sexually transmitted infections (STIs) in this population group.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Highlights from the latest report on STIs from the Centers for Disease Control and Prevention.

Nirsevimab was approved by the FDA on July 17, 2023, ahead of the traditional RSV season, though in October, the Centers for Disease Control and Prevention (CDC) recommended it be prioritized for the highest-risk infants amid limited availability.

Gluten-free meal plans can be a critical treatment option and necessity for those with celiac disease. But for children with no medical conditions or restrictions? A gluten-free diet should not be the mainstay diet.

A high intake of fish and vegetables at 1 year of age was associated with a lower risk of IBD, while consuming sugar-sweetened beverages was linked to a greater risk of developing IBD.

Vivian Hernandez-Truillo, MD, FAAP, FAAAAI, FACAAI; and Theresa Bingemann, MD, provide reaction and commentary regarding recently FDA-approved dupilumab to treat EoE in pediatric patients aged 1 to 11 years.

Deborah Persaud, MD, discusses the background and lead-up to her study examining very early ART in neonates born with HIV-1 and if this treatment could be a step towards ART-free treatment.

Take this quiz and test your knowledge of the American Academy of Pediatrics' recommendations for routine use of influenza vaccines, medications for the prevention and treatment of pediatric influenza.